Dallas, TX
Taysha Gene Therapies is a developer of treatments to eradicate severe & life-threatening monogenic diseases of the central nervous system. Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we are able to rapidly translate our treatments from bench to bedside. We have combined our teamβs proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to quickly and efficiently build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications.
tayshagtx.comThese are collections Taysha Gene Therapies Inc is a part of. Click on the collection name to view similar companies.
Post Ipo Equity
$200,000,000
Post Ipo Equity
$75,000,000
Post Ipo Debt
$40,000,000
Post Ipo Equity
$150,000,000
Post Ipo Equity
$3,000,000
Post Ipo Equity
$50,000,000
Post Ipo Debt
$100,000,000
Series B
$95,000,000
Seed
$30,000,000
IPO
Unknown
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Taysha Gene Therapies Inc.